PRESTIGE CONSUMER HEALTHCARE (PBH) Stock Price, Forecast & Analysis
NYSE:PBH • US74112D1019
PBH Key Statistics, Chart & Performance
The current stock price of PBH is 66.79 USD. In the past month the price increased by 1.8%. In the past year, price decreased by -22.34%.
PBH Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to PBH. When comparing the yearly performance of all stocks, PBH is a bad performer in the overall market: 73.89% of all stocks are doing better.
PBH Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to PBH. Both the health and profitability get an excellent rating, making PBH a very profitable company, without any liquidiy or solvency issues.
PBH Financial Highlights
Over the last trailing twelve months PBH reported a non-GAAP Earnings per Share(EPS) of 4.48. The EPS increased by 6.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 18.09% | ||
| ROA | 5.83% | ||
| ROE | 11% | ||
| Debt/Equity | 0.55 |
PBH Forecast & Estimates
10 analysts have analysed PBH and the average price target is 78.03 USD. This implies a price increase of 16.83% is expected in the next year compared to the current price of 66.79.
For the next year, analysts expect an EPS growth of 1.56% and a revenue growth -2.1% for PBH
PBH Ownership
PBH Latest News, Press Relases and Analysis
PBH Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 30.99 | 981.56B | ||
| JNJ | JOHNSON & JOHNSON | 20.9 | 589.194B | ||
| MRK | MERCK & CO. INC. | 22.44 | 295.956B | ||
| PFE | PFIZER INC | 9.18 | 156.186B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.98 | 121.86B | ||
| ZTS | ZOETIS INC | 18.44 | 55.368B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.71 | 25.86B | ||
| VTRS | VIATRIS INC | 6.23 | 18.186B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.04 | 12.317B | ||
| AXSM | AXSOME THERAPEUTICS INC | 221.27 | 9.222B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PBH
Company Profile
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 600 full-time employees. The company went IPO on 2005-02-10. The firm is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Company Info
PRESTIGE CONSUMER HEALTHCARE
660 White Plains Rd.
Tarrytown NEW YORK 10591 US
CEO: Ronald M. Lombardi
Employees: 600
Phone: 19145246800
PRESTIGE CONSUMER HEALTHCARE / PBH FAQ
What does PRESTIGE CONSUMER HEALTHCARE do?
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 600 full-time employees. The company went IPO on 2005-02-10. The firm is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Can you provide the latest stock price for PRESTIGE CONSUMER HEALTHCARE?
The current stock price of PBH is 66.79 USD. The price decreased by -0.25% in the last trading session.
Does PBH stock pay dividends?
PBH does not pay a dividend.
How is the ChartMill rating for PRESTIGE CONSUMER HEALTHCARE?
PBH has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the PE ratio for PBH stock?
The PE ratio for PRESTIGE CONSUMER HEALTHCARE (PBH) is 14.91. This is based on the reported non-GAAP earnings per share of 4.48 and the current share price of 66.79 USD.
Can you provide the upcoming dividend date for PRESTIGE CONSUMER HEALTHCARE?
The next ex-dividend date for PRESTIGE CONSUMER HEALTHCARE (PBH) is December 30, 2021.
Should I buy PBH stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PBH.